A single vaccine to prevent against both rabies and Ebola has proved effective in mice and holds promise for stemming outbreaks of both diseases, say researchers at Jefferson Vaccine Center at Thomas Jefferson University. "Rabies still poses a health threat for people worldwide, and is especially devastating in developing nations where a post exposure treatment is often not available, and Ebola still exists in parts of Central Africa and is also a chief bioterrorism concern worldwide," said center director Matthias Schnell.

Related Summaries